KOCHI: George (name changed), was 55-years-old when he was diagnosed with fatty liver. Since he was a teetotaller, he did not ...

BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological ...

Polyploidy is a state where a cell contains more copies of the genetic material than the usual "diploid" cell, which contains ...

GERD treatment takes a multidisciplinary approach to controlling symptoms. Here, find home remedies, lifestyle advice, and ...

Weiss highlighted a 2012 Cochrane Library review that examined research and found the drug is “reasonably safe” and prolongs ...

Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that the U.S. Food and Drug ...

A group of researchers at VCU Massey Comprehensive Cancer Center was awarded $13 million by the National Cancer Institute.

The study found bile production is affected by how quickly blood enters the liver via the "portal" vein from the intestine.

An FDA AdCom in September recommended against full approval for Ocaliva by a 13-1 vote for the treatment of primary biliary ...

Discover why Sagimet Biosciences' Denifanstat is a top contender in treating MASH, with FDA designation and strong financials ...

October is Liver Cancer Awareness Month. Liver cancer is the third-leading cause of cancer-related deaths worldwide, and the ...